Cogstate Ltd

CGS

Company Profile

  • Business description

    Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

  • Contact

    161 Collins Street
    Level 2
    MelbourneVIC3000
    AUS

    T: +61 396641300

    https://www.cogstate.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    30 June 2026

    Employees

    249

Stocks News & Analysis

stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
stocks

Palantir earnings: Blockbuster growth amid high expectations

We raise our fair value estimate off the back of earnings.
stocks

ResMed earnings: Solid showing from ASX healthcare winner

Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,111.1082.300.91%
CAC 407,645.4324.390.32%
DAX 4023,869.6623.590.10%
Dow JONES (US)44,111.7461.90-0.14%
FTSE 1009,171.8929.160.32%
HKSE24,910.638.100.03%
NASDAQ20,916.55137.03-0.65%
Nikkei 22540,794.86245.320.60%
NZX 50 Index12,880.163.120.02%
S&P 5006,299.190.000.00%
S&P/ASX 2008,843.7073.300.84%
SSE Composite Index3,633.9916.400.45%

Market Movers